May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Intravenous Administration of Melanin Associated Antigen Inhibits Experimental Autoimmune Anterior Uveitis (EAAU)
Author Affiliations & Notes
  • B. Matta
    Ophthalmology/Jones Eye Institute, Univ of Arkansas Medical Sciences (UAMS), Little Rock, Arkansas
  • P. Jha
    Ophthalmology/Jones Eye Institute, Univ of Arkansas Medical Sciences (UAMS), Little Rock, Arkansas
  • P. S. Bora
    Ophthalmology/Jones Eye Institute, Univ of Arkansas Medical Sciences (UAMS), Little Rock, Arkansas
  • N. S. Bora
    Ophthalmology/Jones Eye Institute, Univ of Arkansas Medical Sciences (UAMS), Little Rock, Arkansas
  • Footnotes
    Commercial Relationships B. Matta, None; P. Jha, None; P.S. Bora, None; N.S. Bora, None.
  • Footnotes
    Support EY13335, EY014623 HIGHWIRE EXLINK_ID="48:5:5210:1" VALUE="EY014623" TYPEGUESS="GEN" /HIGHWIRE , EY016205 HIGHWIRE EXLINK_ID="48:5:5210:2" VALUE="EY016205" TYPEGUESS="GEN" /HIGHWIRE , Research to Prevent Blindness, Inc. NY and the Pat & Willard Walker Eye Research Center, Jones Eye Institute, University of Arkansas for Medical Sciences (Little Rock, AR)
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 5210. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B. Matta, P. Jha, P. S. Bora, N. S. Bora; Intravenous Administration of Melanin Associated Antigen Inhibits Experimental Autoimmune Anterior Uveitis (EAAU). Invest. Ophthalmol. Vis. Sci. 2007;48(13):5210.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To inhibit EAAU by inducing antigen specific tolerance and to investigate the underlying mechanism(s) of suppression.

Methods:: EAAU was induced in Lewis rats by melanin associated antigen (MAA). Different doses of MAA were administered intravenously (iv), intranasally and orally to induce tolerance. Animals were sacrificed at the peak of EAAU and mixed lymphocytes harvested from the eye and the popliteal lymph nodes were cultured in the presence and the absence of MAA. Supernatant and non-adherent T cells were used in the ELISA and RT-PCR respectively for IFN-γ, TNF-α, IL-2, IL-4 and IL-10. Mixed lymphocytes harvested at the onset of EAAU were stained with anti-CD4 and anti-CD25 for flow cytometry. CFSE stained non adherent T cells from LN were analyzed for in vitro proliferative response. For in vivo proliferation, CFSE stained mixed lymphocytes were injected into naïve Lewis rats and CFSE+ve cells were analyzed with flow cytometry. For adoptive transfer of protection, T cells obtained from the popliteal lymph nodes of tolerized and non-tolerized Lewis rats were injected into naïve syngenic animals 24 h before immunization.

Results:: Only intravenous administration of MAA inhibited the induction of EAAU. This inhibition was dose dependent. ELISA and RT-PCR analysis revealed that the expression of IFN-γ, TNF-α and IL-2 were dramatically reduced while IL-4 and IL-10 levels were upregulated in non adherent T cells harvested from tolerized rats compared to non-tolerized animals. CD4+ CD25+ T regulatory cells were increased in the LN of tolerized animals compared to non-tolerized rats. In vivo and in vitro assays revealed that cell proliferation in tolerized animals was significantly lower than that observed in non-tolerized rats. Interestingly, protection was transferred to naïve syngenic animals by the adoptive transfer of tolerized T cells.

Conclusions:: Our data demonstrated that multiple mechanisms are involved in tolerance induction in EAAU. Our results further suggested that IL-2 levels are reduced due to CD4+ CD25+ regulatory T cells leading to reduced proliferative T cell response in the tolerized animals.

Keywords: autoimmune disease • uveitis-clinical/animal model • immune tolerance/privilege 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×